Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clostridium Infections | 20 | 2023 | 559 | 4.300 |
Why?
|
| Inflammatory Bowel Diseases | 22 | 2024 | 2444 | 2.630 |
Why?
|
| Feces | 17 | 2024 | 1515 | 2.410 |
Why?
|
| Enterocolitis, Pseudomembranous | 4 | 2020 | 264 | 1.240 |
Why?
|
| Colitis, Ulcerative | 6 | 2024 | 1930 | 1.060 |
Why?
|
| Lactobacillus | 1 | 2024 | 212 | 0.840 |
Why?
|
| Crohn Disease | 4 | 2024 | 2293 | 0.700 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2023 | 1126 | 0.660 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2020 | 187 | 0.650 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2022 | 389 | 0.630 |
Why?
|
| Demography | 1 | 2022 | 1643 | 0.580 |
Why?
|
| Abdominal Pain | 2 | 2023 | 1070 | 0.570 |
Why?
|
| Diarrhea | 1 | 2023 | 1320 | 0.520 |
Why?
|
| Placebos | 1 | 2020 | 1668 | 0.510 |
Why?
|
| Gastroenterology | 3 | 2019 | 588 | 0.510 |
Why?
|
| Biological Therapy | 2 | 2015 | 140 | 0.500 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 620 | 0.500 |
Why?
|
| Deception | 1 | 2016 | 101 | 0.500 |
Why?
|
| Leukocyte L1 Antigen Complex | 3 | 2021 | 94 | 0.490 |
Why?
|
| Medication Adherence | 3 | 2017 | 2190 | 0.490 |
Why?
|
| Research Subjects | 1 | 2016 | 249 | 0.450 |
Why?
|
| Patient Dropouts | 1 | 2016 | 411 | 0.450 |
Why?
|
| Problem Solving | 1 | 2015 | 443 | 0.420 |
Why?
|
| Organ Transplantation | 1 | 2023 | 1177 | 0.420 |
Why?
|
| Colonoscopy | 4 | 2021 | 1412 | 0.420 |
Why?
|
| Transplantation | 1 | 2013 | 221 | 0.380 |
Why?
|
| Problem-Based Learning | 1 | 2015 | 356 | 0.380 |
Why?
|
| Child | 24 | 2023 | 80863 | 0.370 |
Why?
|
| Recurrence | 7 | 2023 | 8510 | 0.370 |
Why?
|
| Family | 1 | 2020 | 3208 | 0.330 |
Why?
|
| Cost of Illness | 1 | 2017 | 1960 | 0.290 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2339 | 0.290 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2006 | 21 | 0.270 |
Why?
|
| Perception | 1 | 2013 | 1207 | 0.270 |
Why?
|
| Mesenteric Arteries | 1 | 2006 | 178 | 0.260 |
Why?
|
| Aneurysm, Infected | 1 | 2006 | 82 | 0.260 |
Why?
|
| Adolescent | 18 | 2024 | 89168 | 0.250 |
Why?
|
| Caregivers | 1 | 2017 | 2302 | 0.250 |
Why?
|
| Humans | 53 | 2024 | 768451 | 0.250 |
Why?
|
| Treatment Outcome | 12 | 2024 | 65409 | 0.210 |
Why?
|
| Attitude to Health | 1 | 2011 | 2030 | 0.200 |
Why?
|
| Self Care | 2 | 2018 | 798 | 0.190 |
Why?
|
| Therapeutic Equipoise | 1 | 2020 | 29 | 0.180 |
Why?
|
| Quality of Life | 3 | 2017 | 13497 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 8051 | 0.170 |
Why?
|
| Young Adult | 11 | 2024 | 60045 | 0.170 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 61 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2015 | 4841 | 0.160 |
Why?
|
| Adult | 18 | 2024 | 223542 | 0.160 |
Why?
|
| Medication Therapy Management | 1 | 2019 | 131 | 0.150 |
Why?
|
| Antitubercular Agents | 1 | 2006 | 1390 | 0.150 |
Why?
|
| Male | 22 | 2024 | 364781 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 4049 | 0.140 |
Why?
|
| Sick Leave | 1 | 2017 | 105 | 0.140 |
Why?
|
| Self Efficacy | 2 | 2018 | 651 | 0.130 |
Why?
|
| Yersinia Infections | 1 | 2016 | 9 | 0.130 |
Why?
|
| Yersinia enterocolitica | 1 | 2016 | 13 | 0.130 |
Why?
|
| Female | 22 | 2024 | 396943 | 0.130 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2016 | 82 | 0.130 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 271 | 0.120 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2020 | 454 | 0.120 |
Why?
|
| Longevity | 1 | 2022 | 1077 | 0.120 |
Why?
|
| Ethics, Research | 1 | 2016 | 177 | 0.120 |
Why?
|
| Metagenomics | 1 | 2017 | 476 | 0.110 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2012 | 13 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2019 | 1479 | 0.110 |
Why?
|
| Names | 1 | 2012 | 54 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2024 | 8730 | 0.100 |
Why?
|
| Failure to Thrive | 1 | 2012 | 140 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2018 | 1146 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 7471 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 840 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15965 | 0.090 |
Why?
|
| United States | 5 | 2022 | 73121 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2023 | 81834 | 0.090 |
Why?
|
| Students | 1 | 2020 | 1751 | 0.090 |
Why?
|
| Double-Blind Method | 1 | 2024 | 12450 | 0.090 |
Why?
|
| Consensus | 1 | 2019 | 3207 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2018 | 6353 | 0.080 |
Why?
|
| Prognosis | 4 | 2018 | 30028 | 0.070 |
Why?
|
| Linear Models | 1 | 2017 | 5880 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2015 | 4041 | 0.070 |
Why?
|
| Probiotics | 1 | 2011 | 382 | 0.070 |
Why?
|
| Disease Management | 1 | 2018 | 2533 | 0.070 |
Why?
|
| Learning | 1 | 2016 | 1762 | 0.070 |
Why?
|
| Safety Management | 1 | 2012 | 764 | 0.070 |
Why?
|
| Jejunal Diseases | 1 | 2006 | 46 | 0.070 |
Why?
|
| Bacteria | 1 | 2017 | 2226 | 0.060 |
Why?
|
| Duodenal Diseases | 1 | 2006 | 101 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2017 | 2513 | 0.060 |
Why?
|
| Registries | 1 | 2020 | 8373 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2437 | 0.060 |
Why?
|
| Pediatrics | 1 | 2019 | 3622 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 22293 | 0.050 |
Why?
|
| Social Support | 1 | 2012 | 2195 | 0.050 |
Why?
|
| Health Surveys | 1 | 2012 | 4056 | 0.050 |
Why?
|
| Aged | 5 | 2022 | 171520 | 0.050 |
Why?
|
| Middle Aged | 8 | 2021 | 223418 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7451 | 0.050 |
Why?
|
| Metronidazole | 1 | 2022 | 233 | 0.050 |
Why?
|
| Angiography | 1 | 2006 | 1598 | 0.050 |
Why?
|
| Anxiety | 1 | 2016 | 4655 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 20231 | 0.040 |
Why?
|
| France | 1 | 2019 | 497 | 0.040 |
Why?
|
| Social Adjustment | 1 | 2020 | 636 | 0.040 |
Why?
|
| Donor Selection | 1 | 2019 | 240 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 41797 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2012 | 4340 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 26351 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 16029 | 0.030 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Depression | 1 | 2016 | 8235 | 0.030 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 3048 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2019 | 603 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39430 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1292 | 0.030 |
Why?
|
| Universities | 1 | 2020 | 1007 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2019 | 709 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1840 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2022 | 9382 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 18048 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 2408 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22386 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 59680 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2019 | 8081 | 0.030 |
Why?
|
| Living Donors | 1 | 2017 | 651 | 0.030 |
Why?
|
| Infant | 3 | 2022 | 36497 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 1474 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 255 | 0.020 |
Why?
|
| Europe | 1 | 2019 | 3439 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 727 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 13026 | 0.020 |
Why?
|
| Biological Products | 1 | 2019 | 937 | 0.020 |
Why?
|
| Phylogeny | 1 | 2017 | 2846 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 1816 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4545 | 0.020 |
Why?
|
| Risk Factors | 3 | 2019 | 74915 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3955 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4780 | 0.020 |
Why?
|
| Health Services Research | 1 | 2012 | 1815 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3484 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 21552 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3665 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13324 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15460 | 0.010 |
Why?
|
| Parents | 1 | 2017 | 3596 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14728 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2022 | 26395 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14480 | 0.010 |
Why?
|
| Age Factors | 1 | 2017 | 18478 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 42623 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13655 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16712 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2012 | 3858 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 54914 | 0.010 |
Why?
|
| Physicians | 1 | 2012 | 4615 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 82045 | 0.000 |
Why?
|
| Animals | 1 | 2016 | 169418 | 0.000 |
Why?
|
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_